MedPath

Evaluation of Fluconazole treatment effects on acute biliary pancreatitis

Not Applicable
Conditions
biliary acute pancreatitis
biliary acute pancreatitis.
Registration Number
IRCT2013082714333N3
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
76
Inclusion Criteria

patients consists of those who have been diagnosed with acute biliary pancreatitis based on clinical; laboratory and ultrasound results.criteria excluded: Pregnant women; patients with a history of previous hypersensitivity to fluconazole to mention; person that any allergies or suffer from the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of disease. Timepoint: at starting point and six months later. Method of measurement: Based on Ratson criteria and CT. Scan.;Necessity to operation. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Duration of staying in hospita. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Duration of staying in hospital. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Costs of disease. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Treatments. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Complications. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Mortality rate. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath